- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02351336
Fetal Adrenal Gland Volume Estimation Compared to Cervical Length Assessment in Prediction of Preterm Birth
Three - Dimensional Ultrasound Estimation of Fetal Adrenal Gland Enlargement Compared to Assessment of Cervical Changes Alone & Prediction of Impending Preterm Birth
Study Overview
Detailed Description
Preterm birth ( PTB) is one of the leading causes of neonatal morbidity and mortality Early PTB (≤ 34 weeks' gestation) carries a 7-fold increased risk of Neonatal death . Following PTB, survivors can experience significant long term cognitive, behavioral, emotional, sensory, and motor deficits. Hence, there is growing interest in the identification of women who are at Risk for spontaneous PTB. Many biophysical and biochemical markers have been discovered to identify those women who are at risk for spontaneous PTB.
Unfortunately, none of the various maternal and fetal biomarkers such as:
cytokines, CRH, C-reactive protein, fetal fibronectin ,…. etc. are sufficiently sensitive or specific to be used alone or in combination to help decrease the rate of preterm births. Obviously, there's a need for an accurate method with high sensitivity and specificity for prediction of preterm labor. So that an appropriate management or referral to a higher center can be done to women likely to have PTB. Whereas unnecessary tocolytic therapy can be avoided in women who are unlikely to have PTB. Convincing data have shown that 2-dimensional (2D) ultrasound measurement of cervical length (CL) can identify women at risk for PTB.
Accordingly, CL is now widely used in clinical practice for risk estimation. However, as understanding of the mechanisms of preterm labor (PTL) have evolved, obstetricians have learned that, in some women, cervical shortening is a phenomenon that carries no increased risk for prematurity. Therefore, the search for early and accurate markers that distinguish between physiologic processes and abnormal activation of the labor cascade has been ongoing.
Literature has suggested that activation of the fetal hypothalamic-pituitary-adrenal axis play a crucial rule in commencement of labor. A previous study demonstrated that three -dimensional ultrasound measurement of fetal adrenal gland volume (AGV) may identify women at risk for impending PTB. In a more recent study receiver operator characteristics (ROC) curve analysis revealed that three -dimensional ultrasound measurement of (AGV) was superior to two-dimensional ultrasound measurement of (AGV) for anticipation of PTB within 7 days of the scan. The aim of this study is to investigate the utility of 3D fetal adrenal gland volume measurement in the early prediction of PTB and to determine whether these measurements could be combined with 2D ultrasound cervical assessment to improve the early prediction of PTB.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Wessam M Abouelghar, MD
- Phone Number: 002-01227460679
- Email: dr.awessam@gmail.com
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Ain Shams Maternity Hospital
-
Contact:
- Wessam M Abouelghar, MD
- Phone Number: 002-01227460679
- Email: dr.awessam@gmail.com
-
Contact:
- R
-
Sub-Investigator:
- Rania A Rizk, M.B, B.Ch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Women who are diagnosed as having threatened preterm labour based on the American college of obstetricians and gynaecologists guidelines (ACOG,2003) :
- Presence of uterine contractions ( at least 4 in 20 minutes or 8 in 60 minutes )
- Cervical dilataion >1cm, &/or
- Cervical effacement ≥ 80%
Description
Inclusion Criteria:
- Age : 18 - 40 years
- Gestational age: 26 - 35 weeks , which is going to be calculated according to the date of last menstrual period & confirmed by first trimester ultrasonography .
Women who are diagnosed as having threatened preterm labour based on the American college of obstetricians and gynaecologists guidelines (ACOG,2003) :
- Presence of uterine contractions ( at least 4 in 20 minutes or 8 in 60 minutes )
- Cervical dilataion >1cm, &/or
Cervical effacement ≥ 80% 4. Women having one or more of the following:
- Multifetal pregnancy .
- Previous preterm labor or premature birth, particularly in the most recent pregnancy or in more than one previous pregnancy
Exclusion Criteria:
- Suspected fetal growth restriction .
- Preterm premature rupture of the membranes : confirmed by visualization of amniotic fluid vaginal pooling at the time of sterile speculum examination .
- Patients with antepartum haemorrhage ( due to placental abruption &/or placenta previa )
- Presence of fetal anomalies incompatible with life. 5 - Patients who are not sure of dates
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
threatened preterm labour
Women who are diagnosed as having threatened preterm labour based on the American college of obstetricians and gynaecologists guidelines (ACOG,2003) :
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
1. Accurate prediction of impending preterm birth using 3D ultrasound estimation of fetal adrenal gland volume
Time Frame: within 7 days of ultrasound scan
|
within 7 days of ultrasound scan
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Superiority of Adrenal gland volme estimation in prediction of preterm birth compared to cervical length measurement alone
Time Frame: 7 days of ultrasound scan
|
7 days of ultrasound scan
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Wessam M Abouelghar, MD, Ain Shams Maternity Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PTB 012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Preterm Labour
-
Ain Shams UniversityCompleted
-
University Hospital Inselspital, BerneAmniSure International LLCCompletedPreterm Birth | Preterm LabourSwitzerland
-
Assiut UniversityCompleted
-
Cairo UniversityUnknown
-
Tawam HospitalCompleted
-
Assistance Publique Hopitaux De MarseilleCompletedPatients With a Risk of Preterm LabourFrance
-
Centre Hospitalier Universitaire DijonCompleted
-
Mohamed Sayed AbdelhafezCompleted
Clinical Trials on Ultrasound imaging
-
The Hospital for Sick ChildrenCompleted
-
Mayo ClinicNational Cancer Institute (NCI); National Institute for Biomedical Imaging...RecruitingBreast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Mayo ClinicTerminated
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Baylor College of MedicineUniversity of Texas Southwestern Medical Center; Cancer Prevention Research...RecruitingHuman Papillomavirus InfectionUnited States
-
National Cancer Institute (NCI)Active, not recruitingOvarian Carcinoma | Ovarian Germ Cell TumorUnited States
-
Sunnybrook Health Sciences CentreRecruitingHead and Neck Cancer | Rectal Cancer | Prostate CancerCanada
-
Ohio State University Comprehensive Cancer CenterWithdrawn
-
Rijnstate HospitalRadboud University Medical CenterRecruitingCarotid Artery StenosisNetherlands